Rx drug advertising coalition
First meeting of the group of manufacturers, advertisers, broadcasters and lawyers, scheduled for Feb. 23, has been postponed for at least 60 days. In the interim, coalition's executive committee will develop and refine recommendations for charter activities geared toward easing FDA direct-to-consumer advertising requirements and mollifying Capitol Hill criticism. Rep. Waxman (D-Calif.) recently objected to aspirin heart attack ads an direct Rx ads ("The Pink Sheet" Feb. 15, p. 3). Coalition now has a total of 52 supporters including drug companies and associations.
You may also be interested in...
Tests used to detect cytomegalovirus in organ transplant patients may face an easier path to market under a proposed rule that the US Food and Drug Administration released on 18 September. See what the regulatory agency said about it here.
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.
ACIP defers vote on who should be inoculated first until it has data on a specific product, but vaccine acceptance among different groups could be weighed as factor in setting distribution priorities, committee members suggest.